APA

Sarau H. M., Foley J. J., Schmidt D. B., Tzimas M. N., Martin L. D., Daines R. A., Chambers P. A., Kingsbury W. D. & Griswold D. E. (19950531). SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity. : Advances in prostaglandin, thromboxane, and leukotriene research.

Chicago

Sarau H M, Foley J J, Schmidt D B, Tzimas M N, Martin L D, Daines R A, Chambers P A, Kingsbury W D and Griswold D E. 19950531. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity. : Advances in prostaglandin, thromboxane, and leukotriene research.

Harvard

Sarau H. M., Foley J. J., Schmidt D. B., Tzimas M. N., Martin L. D., Daines R. A., Chambers P. A., Kingsbury W. D. and Griswold D. E. (19950531). SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity. : Advances in prostaglandin, thromboxane, and leukotriene research.

MLA

Sarau H M, Foley J J, Schmidt D B, Tzimas M N, Martin L D, Daines R A, Chambers P A, Kingsbury W D and Griswold D E. SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity. : Advances in prostaglandin, thromboxane, and leukotriene research. 19950531.